Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris
- 26 January 1991
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 337 (8735), 193-196
- https://doi.org/10.1016/0140-6736(91)92157-w
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Treatment of Psoriasis by the Topical Application of the Novel Cholecalciferol Analogue Calcipotriol (MC 903)Archives of Dermatology, 1989
- A double-blind, placebo-controlled trial of topical 1,25-dihydroxycholecalciferol in psoriasisBritish Journal of Dermatology, 1989
- A double-blind study of topical 1α,25-dihydroxyvitamin D3 in psoriasisBritish Journal of Dermatology, 1989
- A novel approach for the evaluation and treatment of psoriasis: Oral or topical use of 1,25-dihydroxyvitamin D3 can be a safe and effective therapy for psoriasisJournal of the American Academy of Dermatology, 1988
- Improvement of psoriasis by a topical vitamin D3 analogue (MC 903) in a double-blind studyBritish Journal of Dermatology, 1988
- Effects of a novel vitamin D analogue MC 903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivoBiochemical Pharmacology, 1988
- 1,25-Dihydroxyvitamin D3 action and receptors in endothelial and smooth muscle cells of arterial vesselsActa Endocrinologica, 1987
- Synthesis of mc 903, a biologically active vitamin D metabolite analogueTetrahedron, 1987
- Effect of 1α,25-Dihydroxyvitamin D3 on the Morphologic and Biochemical Differentiation of Cultured Human Epidermal Keratinocytes Grown in Serum-Free ConditionsJournal of Investigative Dermatology, 1986
- Severe Psoriasis – Oral Therapy with a New RetinoidDermatology, 1978